Michele Baltay

Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Sara M. Tolaney, Hao Guo, Sònia Pernas et al. · Journal of Clinical Oncology · 2019 · 276 citations · Full text

SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma

David L. Kolin, Fei Dong, Michele Baltay et al. · Modern Pathology · 2018 · 162 citations · Full text

Tumor Biology, Clinicopathologic Entity, Tumoral Pathology +9

Randomized trial of 10 days of decitabine ± bortezomib in untreated older patients with AML: CALGB 11002 (Alliance)

Gail J. Roboz, Sumithra J. Mandrekar, Pinkal Desai et al. · Blood Advances · 2018 · 55 citations · Full text

Molecular Characterization of Neuroendocrine Carcinomas of the Endometrium

Brooke E. Howitt, Fei Dong, Marina Vivero et al. · The American Journal of Surgical Pathology · 2020 · 38 citations

Gene expression profiling distinguishes prefibrotic from overtly fibrotic myeloproliferative neoplasms and identifies disease subsets with distinct inflammatory signatures

Waihay J. Wong, Michele Baltay, Annaliese Getz et al. · PLoS ONE · 2019 · 31 citations · Full text